SKI Market

Indian Indices

Nifty

25,149.85 -205.40
(-0.81%)

Sensex

82,500.47 -689.81
( -0.83%)

Bank Nifty

56,754.70 -201.30
( -0.35%)

Nifty IT

37,693.25 -683.40
( -1.78%)

Global Indices

Nasdaq

44,384.39 -287.26
(-0.64%)

Dow Jones

6,279.98 -21.48
(-0.34%)

Hang Seng

39,553.98 -92.38
(-0.23%)

Nikkei 225

8,941.12 -34.54
(-0.38%)

Forex

USD-INR

85.68 -0.05
(-0.06%)

EUR-INR

100.36 -0.05
(-0.05%)

GBP-INR

116.41 -0.07
(-0.06%)

JPY-INR

0.59 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Piramal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543635

INE0DK501011

56.1026791

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PPLPHARMA

38.71

26704.59

EPS(TTM)

Face Value()

Div & Yield %

5.19

0.07

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	5285.71	4390.11	3443.22	3340.42	2938.81
Excise Duty	0.00	0.00	0.00	0.00	0.00
Net Sales	5285.71	4390.11	3443.22	3340.42	2938.81
Other Income	207.35	202.06	341.07	224.79	216.20
Stock Adjustments	84.57	61.62	-53.31	32.66	-57.86
Total Income	5577.63	4653.79	3730.98	3597.87	3097.15
EXPENDITURE :
Raw Materials	2330.53	2170.46	1715.17	1594.17	1169.91
Power & Fuel Cost	131.62	112.89	107.94	83.83	68.08
Employee Cost	736.19	613.93	548.50	448.03	395.15
Other Manufacturing Expenses	284.35	251.57	259.29	299.83	252.74
Selling & Administrative Expenses	746.69	620.04	485.63	427.82	258.75
Miscellaneous Expenses	100.46	64.92	182.81	59.20	117.39
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00
Total Expenditure	4329.84	3833.81	3299.34	2912.88	2262.02
Operating Profit	1247.79	819.98	431.64	684.99	835.13
Interest	114.56	107.10	115.87	57.29	4.71
Gross Profit	1133.23	712.88	315.77	627.70	830.42
Depreciation	222.09	205.26	192.08	165.37	143.64
Profit Before Tax	911.14	507.62	123.69	462.33	686.78
Tax	199.44	112.48	38.77	110.82	104.98
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00
Deferred Tax	20.30	3.92	15.42	-16.03	10.30
Reported Net Profit	691.40	391.22	69.50	367.54	571.50
Extraordinary Items	1.24	3.34	-3.14	-10.64	15.44
Adjusted Net Profit	690.16	387.88	72.64	378.18	556.06
Adjustment below Net Profit	1.05	-3.79	-2.59	31.70	-2.46
P & L Balance brought forward	1359.23	971.79	918.28	569.04	0.00
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00
Appropriations	14.47	0.00	13.40	50.00	0.00
P & L Balance carried down	2037.21	1359.22	971.79	918.28	569.04
Dividend	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	1.40	1.10	0.00	5.60	0.00
Dividend Per Share(Rs)	0.14	0.11	0.00	0.56	0.00
Earnings Per Share-Unit Curr	5.22	2.96	0.58	3.10	5.75
Earnings Per Share(Adj)-Unit Curr	5.22	2.96	0.57	3.10	5.75
Book Value-Unit Curr	56.27	50.74	44.09	43.20	41.23
Book Value(Adj)-Unit Curr	56.27	50.74	43.06	43.20	41.23

25,149.85 -205.40 (-0.81%)

82,500.47 -689.81 ( -0.83%)

56,754.70 -201.30 ( -0.35%)

37,693.25 -683.40 ( -1.78%)

44,384.39 -287.26 (-0.64%)

6,279.98 -21.48 (-0.34%)

39,553.98 -92.38 (-0.23%)

8,941.12 -34.54 (-0.38%)

85.68 -0.05 (-0.06%)

100.36 -0.05 (-0.05%)

116.41 -0.07 (-0.06%)

0.59 0.00 (0.19%)